Company

Tallac Therapeutics

Biotechnology Research 866 Malcom Rd 19 employees

Employees: 19
Contacts: 3
Emails: 3
Phones: 2

tallactherapeutics.com LinkedIn Crunchbase

Tallac Therapeutics Overview

Headquarters: 866 Malcom Rd
Website: tallactherapeutics.com
Industry: Biotechnology Research
Employees: 19
Funding: 5.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Tallac Therapeutics

Tallac Therapeutics is a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer. Tallac’s pipeline of immunotherapy candidates are derived from the company’s novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform to deliver a potent Toll-like receptor (TLR9) agonist (T-CpG) for targeted immune activation via systemic administration. Several TRAAC molecules are in various stages of discovery and preclinical development.

Tallac Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

Tallac Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Pavel Strop		San Francisco Bay Area, United States	Email Phone
Curtis Hecht	Chief Business Officer at Tallac Therapeutics	South San Francisco, California, United States	Email Phone
Laura Qm C.	CMO, Executive Clinical Development Leader, Oncology Consultant, Kol Thoracic, Head and Neck and Solid Tumors	Austin, Texas Metropolitan Area, United States	View
Peter Dudek		Cambridge, Massachusetts, United States	Email